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Purpose: Low back pain (LBP) is one of the most frequent reasons for medical consulta-
tions. Literature suggests a large evidence-performance gap, especially regarding pain 
management. Therefore, the monitoring of treatment patterns is important to ensure high 
quality of treatment. This study aimed to describe treatment patterns specific to patients with 
diagnostic imaging of the spine for LBP.
Patients and Methods: The study was retrospective observational and based on health 
claims data from 2015 to 2019 provided by a Swiss health insurance company covering 
around 12% of the population. Patients, ≥18 years of age, with diagnostic imaging of the 
spine were included and observed 12 months before and after imaging. Patients with back 
surgery or comorbidities associated with the use of pain medications were excluded.
Results: In total, 60,822 patients (mean age: 53.5 y, 56.1% female) were included and 85% 
received at least one pain medication. Of these, non-steroidal anti-inflammatory drugs, 
paracetamol, or opioids were prescribed in 88.6%, 70.7%, and 40.3% of patients, respec-
tively. Strong opioids were used in 17% of patients given opioids. Patients with combinations 
of diagnostic imaging methods had the highest odds of receiving pain medication prescrip-
tions (1.81, 95% CI: 1.66, 1.96, P < 0.001). Prescribed defined daily doses corresponded to 
short-term therapies.
Conclusion: Although the majority of patients received non-opioid short-term therapies, we 
found a substantial use of opioids, and in particular, a relative high usage of strong opioids. 
Our results highlighted the importance of both patient and healthcare provider awareness 
regarding the prudent treatment of LBP.
Keywords: low back pain medication, radiology, diagnostic imaging, NSAIDs, opioids, 
non-pharmacologic therapies
Introduction
Low back pain (LBP) is one of the most common complaints of the general 
population1 and a frequent reason for medical consultations.2 Most international 
guidelines recommend pain medication therapy with non-steroidal anti-inflamma-
tory drugs (NSAIDs) and, only if necessary, opioids.3 However, a large evidence- 
performance gap can be observed in clinical practice regarding guideline- 
compliance.4,5 Of particular interest is treatment with opioids. Their generous use 
can easily lead to addiction and thus become a major public health problem, as can 
currently be observed in the USA.6,7 The monitoring of treatment quality and 
treatment patterns is imperative to all stakeholders involved in the maintenance 
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and promotion of high quality of care. Studies determining 
treatment patterns specific to patients with diagnostic ima-
ging of the spine are lacking. Thus, the aim of this study 
was to determine and characterize treatment patterns, 
including pain medication therapies and non-pharmacolo-
gic therapies (NPT), in patients who had undergone diag-
nostic imaging for LBP. First, we sought the proportion of 
patients receiving specific classes of pain medication 
depending on the time of diagnostic imaging. We then 
examined associations between prescriptions and diagnos-
tic imaging methods. In addition, we investigated the 
effect of the most commonly used NPT on pain medication 
treatment.
Patients and Methods
Study Design and Database
We conducted a retrospective observational study, using 
medical health claim data from 2015 to 2019 provided by 
Groupe Mutuel (GM). GM is one of the largest health 
insurance companies in Switzerland; it insured around 
12% of the Swiss population during our observation per-
iod. GM insured patients in all parts of Switzerland with a 
higher proportion of insured in the French-speaking part 
(up to one third of the population) compared to the 
German-speaking part (maximum of 16%). In 
Switzerland, all citizens have compulsory health insurance 
that covers medical treatments and thus there is no dis-
tinction between public and private systems.
Inclusion and Exclusion Criteria
Diagnostic imaging of the spine was used as a surrogate 
for LBP. Patients were identified by tarif medical 
(TARMED) codes for diagnostic imaging of the spine. In 
the Swiss healthcare system, TARMED codes are used to 
code medical procedures for billing purposes. All patients 
≥18 years of age with a relevant TARMED code in 2016 
or 2017 (index years) were included. The TARMED codes 
considered were specific for the lumbar spine (39.0150 
and 39.0155 [x-ray of the lumbar spine, first image, and 
further images]) or unspecific for the spine (39.4100 [com-
puted tomography (CT) of the spine], and 39.5060 (mag-
netic resonance imaging [MRI] of the spine)). Patients 
with a combination of an unspecific TARMED code (CT 
or MRI of the spine) and a specific TARMED code for an 
adjacent anatomic region were excluded (for example 
simultaneous codes for CT of the spine and CT of the 
skull) as these combinations could indicate that the 
pathology was not exclusively related to the lumbar 
spine. Patients who had undergone back surgery in the 
index year or the previous year were excluded. Finally, 
we excluded all patients with a Pharmaceutical Cost Group 
(PCG) code for a comorbidity which was generally asso-
ciated with pain medication therapy (addiction, cancers 
[hormone sensitive tumors, cancer, cancer complex], rheu-
matism, chronic pain, and neuropathic pain). PCGs were 
used to identify patients with cost-intensive chronic dis-
eases in the Swiss healthcare system. PCGs were based on 
the linkage between medication, defined by the 
Anatomical Therapeutic Chemical Classification System 
(ATC) codes, and specific medical diagnoses. For exam-
ple, patients who had been prescribed a certain dosage of 
antidepressants were given the PCG code for depression. 
A full list of exclusion codes is listed in the Supplementary 
data, Appendix 1.
Data Description
Treatment patterns analyzed in this study included pain 
medication therapies (opioid and non-opioid) and NPT. 
GM provided anonymized medical data from 12 months 
before and up to 12 months after the index imaging. Data 
included basic epidemiological characteristics (age, gen-
der, and insurance status), existing comorbidities, pre-
scribed drugs, and usage of specific healthcare services. 
The latter was used to identify and define NPT: occupa-
tional therapy, physiotherapy, and chiropractic therapy. 
Identification of comorbidities was based on PCG codes. 
ATC codes were used to identify prescriptions of pain- 
medications (systemic NSAIDs and topical diclofenac, 
paracetamol, and opioids). All used ATC codes are pro-
vided within Supplementary Data, Appendix 1. Defined 
Daily Doses (DDD) were calculated for each ATC code.8 
Regarding prescribed medication, we defined five time 
periods of interest: 1) Period 1, from 12 to 7 months before 
index imaging; 2) Period 2, from 6 months before to the 
day of index imaging; 3) Period 3 (only for patients with 
more than one index imaging in the index year), time 
between first and last index image in the index year; 4) 
Period 4, from day 1 to 6 months after index imaging; 5) 
Period 5, from 7 to 12 months after index imaging. 
Regarding the Swiss insurance model, two main groups 
were identified: managed care insurance, where a health-
care manager (a family doctor [family physician model], a 
network [network model], or a specialized telemedicine 
call-center [telemedicine model]) acted as a gatekeeper; or 
a free choice model, where insured patients had full 
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freedom to receive treatment from doctors and specialists 
of their choice. Owing to applicable regulations provided 
by GM we analyzed a random selected subset of around 
92% of all identified patients.
Statistics
Data describing basic characteristics were presented as num-
bers (percentage, %) or means (standard deviation, SD) 
where appropriate. Group comparisons according to diagnos-
tic image were performed using chi-square tests, for catego-
rical variables, or ANOVA test, for continuous variables. 
Pain medication prescriptions were reported, by time period, 
as a number (percentage, %), and as a median (interquartile 
range, IQR) per patient. Comparisons of number (percentage, 
%) between time before imaging (Periods 1 and 2) and after 
imaging (Periods 4 and 5) were performed using chi-square 
tests. Defined Daily Doses, (DDD) depending on time of 
prescription and imaging method, were shown as median 
(IQR). Comparisons between time period before imaging 
and after imaging, were performed using the Kruskal– 
Wallis test. Logistic regression analysis was performed to 
identify the association of imaging and time period (before or 
after imaging separately) with specific prescriptions 
(NSAIDs, opioids, and paracetamol). Odds ratios and con-
fidence intervals were shown graphically. Correction for 
repeated measurements was not necessary, because data 
were summarized so that there was one observation before 
and one after imaging for each patient, and two separate 
regressions were performed. Use of NPT, described as num-
ber (percentage, %) was compared between time periods, for 
patients with pain medications, and between patients with 
and without medications using chi-square tests. For all tests, 
P ≤ 0.05 was considered statistically significant. All analyses 
were carried out using statistical package R (https://www.R- 
project.org).
Ethics
Analysis of full anonymized and aggregated data from 
healthcare insurances did not fall under the Swiss 
Federal Act on Research involving Human Beings 




A total of 60,822 patients (mean age: 53.5 y, 56.1% 
female) were included in the study (Figure 1, Table 1). 
MRI (44.5%) and X-ray (34%) were the most commonly 
performed single diagnostic imaging methods. In patients 
with a combination of diagnostic imaging studies (X-ray/ 
MRI and X-ray/CT) the proportion of patients with the 
X-ray before, after, or on the same day as an MRI/CT was 
66.4%, 15.9%, and 17.7%; and 56.1%, 18.6%, and 25.3%, 
respectively. In the year of imaging, 19.4% of the patients 
had one comorbidity and 5.6% two or more comorbidities. 
Patients with a CT of the spine (CT alone or in combina-
tion with an X-ray) were older on average and had more 
comorbidities compared to patients with an X-ray or MRI 
(mean age 59.32 vs 52.83 y; mean number of comorbid-
ities 0.42 vs 0.3, P < 0.001 for both comparisons).
Pain Medication Therapies
Throughout the whole observation period, 51,900 patients 
(85.3%) received at least one pain medication and 5678 
(9.3%) patients received pain medication in all periods. 
The proportion of patients with pain medication therapy 
was higher in patients with a combination of imaging 
studies (X-ray/MRI or X-ray/CT) compared to patients 
with one imaging only (P < 0.001 for all comparisons): 
any prescription (90.8% vs 84.6%), NSAID (82.7% vs 
74.7%), paracetamol (64.6% vs 59.7%), and opioids 
(45.7% vs 32.8%). Patients with combinations of diagnos-
tic imaging methods had the highest odds of pain medica-
tion prescriptions (OR: 1.81. 95% CI: 1.66, 1.96, P < 
0.001). In patients with a pain medication prescription, 
NSAIDs, paracetamol, or opioids were prescribed in 
88.6%, 70.7%, and 40.3%, respectively. Moreover, 
61.9% of patients with NSAID therapy had proton pump 
inhibitor (PPI) co-medication. Considering only patients 
with an opioid prescription, 17% of patients in this group 
were prescribed a strong opioid. Moreover, strong opioids 
accounted for 30.7% of all opioid prescriptions. The odds 
of receiving a specific class of pain medication was depen-
dent on the imaging method used and on the timing of 
prescription (Figure 2).
Detailed prescription patterns for all time periods are pre-
sented in Table 2. We found that the prescription rates were 
stable within the whole observation period with a median of 
one prescription (IQR 1–2) for almost all drugs and time 
periods. During the whole observation period, ibuprofen, 
diclofenac, and mefenamic acid were the most commonly 
used NSAIDs and tramadol (alone and in combination with 
paracetamol) the most commonly used opioid. However, the 
relative use of different substances differed significantly in 
relation to the timing of prescription (Supplementary Data 
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Table 1). In the year after a diagnostic imaging, we found that 
it was more common for strong opioids to be prescribed 
compared to the period before imaging. The most common 
treatment patterns regarding the use of drug classes were 
NSAID monotherapies and combination therapies with 
NSAIDs and paracetamol (Figure 3).
Figure 1 Flowchart of inclusion of 60,822 patients with low back pain. Gray shaded area: The measuring unit was individual patients (vs patient data sets, in which patients can be listed 
twice). #Patients with a combination of an unspecific index imaging of the spine and a specific imaging of an adjacent anatomical region, which suggested that the pathology was not 
exclusively in the lumbar spine, were excluded. *Due to internal regulations of the insurance company, a random sample of approximately 92% was analyzed.
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Regarding the dosage of prescribed drugs (Table 3), we 
found that the median prescribed DDDs of NSAIDs and 
paracetamol corresponded to two to three weeks of therapy, 
independently of the imaging method or observation period. In 
contrast, the median prescribed DDDs of opioid therapies 
corresponded to shorter therapy durations of approximately 5 
to 10 days only. For most substances and regardless of the 
diagnostic imaging method used, we found significantly 
higher amounts of DDDs prescribed in the year after the 
imaging compared to the year before (Supplementary Data 
Table 2).
Information on the use of NPT was available for 
60,359 patients (99.2%). Furthermore, 42,039 (69.6%) 
patients used at least one variety of NPT. Patients using 
NPT differed from patients without NPT in terms of age 
(mean age 54.1 vs 52.4 y), gender (female: 59.7% vs 
48.6%), and the number of comorbidities (mean number: 
0.34 vs 0.28) (P < 0.001 for all comparisons, 
Supplementary Data Table 3). Physiotherapy, chiropractic 
therapy, and occupational therapy were used in 65.9%, 
11.3%, and 2.7% of patients, respectively. NPT were 
more common in patients with a concomitant pain medi-
cation therapy compared to those without (physiotherapy: 
68.8% vs 49.2%, chiropractic therapy: 11.5% vs 10%, 
occupational therapy: 2.9% vs 1.2%; P < 0.001 for all 
comparisons). Independently of the prescribed pain medi-
cation class, patients with NPT received more prescrip-
tions and higher amounts of DDDs (P ≤ 0.001 for all 
comparisons; Supplementary Data Table 4).
Discussion
In this study, we analyzed treatment patterns in 60,822 
patients who had undergone diagnostic imaging of the 
spine because of LBP. We observed that only a minor-
ity of patients with pain medication therapy received 
different pain medications and the mean amount of 
prescribed pain medications corresponded to short- 
term therapies. We found a substantial use of opioids 
and within opioid prescriptions a high proportion 
(31%) were for strong opioids. Finally, the usage of 
NPT was associated with higher amounts of prescribed 
pain medications.
Spine Imaging and Associated Treatment 
Patterns
Although often inappropriate, radiological imaging of 
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our study, MRI was the most common imaging method, 
surpassing X-ray. The relative distribution of the type 
of imaging used varied widely between different 
studies and settings and may be influenced by different 
national guidelines, but X-ray examinations are in gen-
eral the most commonly reported modalities.3–5,11–14 
Figure 2 Odds ratios for prescribing pain medications dependent on the kind of diagnostic imaging method. Time periods before (Period 1 and 2) and after (Period 4 and 5) 
the diagnostic imaging were analyzed separately. Patients with an X-ray only were used as the reference group. P-values are labelled beside the confidence intervals. 
Abbreviations: NSAID, non-steroidal anti-inflammatory drug; MRI, magnetic resonance imaging; CT, computed tomography scan; NPT, non-pharmacologic therapies.
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Table 2 Pain Medication Therapies in 51,900 Patients
Time Periods 1 2 3 4 5
Patients, N 20,433 38,831 1913 31,988 20,574
Prescriptions/per patient, Median [IQR]
NSAID 1.00 [1.00, 2.00] 1.00 [1.00, 2.00] 1.00 [1.00, 2.00] 1.00 [1.00, 2.00] 1.00 [1.00, 2.00]
Paracetamol 1.00 [1.00, 1.00] 1.00 [1.00, 2.00] 1.00 [1.00, 1.00] 1.00 [1.00, 1.00] 1.00 [1.00, 1.00]
Opioid 1.00 [1.00, 2.00] 1.00 [1.00, 2.00] 1.00 [1.00, 2.00] 1.00 [1.00, 2.00] 1.00 [1.00, 2.00]
NSAID
Patients, total 14,382 31,349 1338 23,354 14,085
Prescriptions, total 20,448 52,127 1933 35,748 19,828
Specific prescriptionsa
Indometacin 42 (0.2) 84 (0.2) 2 (0.1) 84 (0.2) 39 (0.2)
Diclofenac 3821 (18.7) 12,293 (23.6) 478 (24.7) 7086 (19.8) 3517 (17.7)
Etodolac 241 (1.2) 898 (1.7) 49 (2.5) 686 (1.9) 324 (1.6)
Ketorolac 374 (1.8) 1036 (2.0) 47 (2.4) 647 (1.8) 364 (1.8)
Diclofenac combinations 165 (0.8) 496 (1.0) 10 (0.5) 357 (1.0) 178 (0.9)
Ibuprofen 8274 (40.5) 20,100 (38.6) 720 (37.2) 14,189 (39.7) 8041 (40.6)
Naproxen 265 (1.3) 870 (1.7) 47 (2.4) 575 (1.6) 287 (1.4)
Naproxen/Esomeprazole combination 539 (2.6) 2058 (3.9) 91 (4.7) 1429 (4.0) 678 (3.4)
Mefenamic acid 2252 (11.0) 4089 (7.8) 126 (6.5) 3182 (8.9) 1944 (9.8)
Celecoxib 385 (1.9) 999 (1.9) 53 (2.7) 972 (2.7) 393 (2.0)
Diclofenac topical 4090 (20.0) 9204 (17.7) 310 (16.0) 6541 (18.3) 4063 (20.5)
Paracetamol
Patients, total 10,802 20,642 740 16,846 10,921
Prescriptions, total 13,418 27,608 925 22,231 13,554
Opioids
Patients, total 4114 11,538 754 9107 4363
Prescriptions, total 5694 16,976 1047 14,436 6191
Specific prescriptions a
Fentanyl 545 (9.6) 910 (5.4) 57 (5.4) 1264 (8.8) 705 (11.4)
Morphine 250 (4.4) 864 (5.1) 38 (3.6) 937 (6.5) 439 (7.1)
Hydromorphone 15 (0.3) 49 (0.3) 5 (0.5) 111 (0.8) 46 (0.7)
Nicomorphine 1 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Dihydrocodeine 25 (0.4) 43 (0.3) 3 (0.3) 45 (0.3) 22 (0.4)
Oxycodone and naloxone 394 (6.9) 1076 (6.3) 95 (9.1) 1459 (10.1) 615 (9.9)
Codeine, combinations 703 (12.3) 1422 (8.4) 62 (5.9) 739 (5.1) 132 (2.1)
Pethidine 153 (2.7) 247 (1.5) 4 (0.4) 265 (1.8) 119 (1.9)
Buprenorphine 74 (1.3) 191 (1.1) 9 (0.9) 255 (1.8) 90 (1.5)
Nalbuphine 1 (0.0) 3 (0.0) 0 (0.0) 5 (0.0) 2 (0.0)
Tramadol and paracetamol 766 (13.5) 2663 (15.7) 184 (17.6) 2072 (14.4) 864 (14.0)
Tilidine 3 (0.1) 11 (0.1) 1 (0.1) 12 (0.1) 8 (0.1)
Tramadol 2622 (46.0) 9100 (53.6) 559 (53.4) 6716 (46.5) 2925 (47.2)
Tapentadol 142 (2.5) 397 (2.3) 30 (2.9) 556 (3.9) 224 (3.6)
Notes: Time periods are defined as follows: 12 to 7 months prior first imaging (Period 1), 6 months to day of imaging (Period 2), time between imaging (Period 3, only 
applicable for patients with >1 imaging studies), day after to 6 months after imaging (Period 4), 7 to 12 months after imaging (Period 5). aNumbers in the specific 
prescriptions section are presented as absolute prescriptions and percentage (in parenthesis). 
Abbreviations: N, number of patients; NSAID, non-steroidal anti-inflammatory drug; IQR, interquartile range.
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However, although MRI or CT are superior to X-ray in 
many diagnostic issues15,16 and one could observe an 
increasing use of MRI/CT,17 the common use of X-rays 
in our study sample may have been owing to easier and 
more timely access to X-ray equipment. In accordance 
with international guidelines3 and similar to observa-
tional data from the USA or Italy,5,18 our study showed 
a high percentage of pain medication prescriptions 
(85%). Patients with combinations of diagnostic ima-
ging methods, in particular X-ray/CT, had the highest 
odds of pain medication prescriptions. Indeed, combi-
nations of diagnostic imaging methods, especially CT 
imaging, could represent a surrogate of more severe 
diseases and the severity of LBP is a known factor 
affecting imaging rates and prescribed medication 
patterns.12 In fact, patients with a CT were older on 
average and had more comorbidities compared to the 
remaining patients.
Non-Opioid Pain Medication Therapies
We noted a high percentage of NSAID use (89% of patients 
with any pain medication) which is in line with many 
international guidelines3 and national guidance,19 that 
recommend the use of NSAIDs as first line treatment 
options. Furthermore, our prescribing patterns were similar 
to those reported in a recent study which analyzed pharma-
cological treatment patterns in LBP patients in the Swiss 
primary care setting but regardless of diagnostic spine 
imaging.20 In accordance with the available national 
guidance,19 Ibuprofen, diclofenac, and mefenamic acid 
were the most commonly used medications and accounted 
for nearly 90% of all NSAID prescriptions. Alternative 
NSAIDs such as COX-2 inhibitors were only marginally 
used. In the observation period following the diagnostic 
imaging we noticed minor but significant changes in the 
relative use of different NSAIDs. However, the overall 
prescribing patterns were not affected by these minor 
changes. Paracetamol, which has a lower recommendation 
for acute LBP,3 was still prescribed in 71% of cases. 
Independent of the used drug and observation period, pre-
scribing patterns seemed to be conservative, as patients with 
NSAID or paracetamol treatments had one prescription at 
the median, while the upper IQR did not surpass two pre-
scriptions. Additionally, the median prescribed DDDs cor-
responded to treatment durations of two to three weeks, 
with slightly longer treatment durations in patients with a 
combination of images and in patients taking paracetamol.
Opioid Pain Medication Therapies
Despite the questionable effect of opioids in acute 
LBP21 and the evidence of poorer outcomes compared 
to non-opioid treatments,22,23 opioids are still frequently 
prescribed for patients with LBP.5,24–26 In our study 
34% of all patients received an opioid. Comparing this 
percentage of opioid use to the sparse national compara-
tive data,20 we found that the percentage in our study 
was almost twice as high. In addition, we discovered 
higher percentages of strong opioid use, although 
Figure 3 Overview of the use of different pain medications. Left part of the figure (Single) shows the usage of single pain medications and the right part of the figure 
(Combinations) shows the usage of combined pain medications. All bars of a specific time period sum to 100%. All: Combination of NSAID, paracetamol, and opioid. 
Abbreviation: NSAIDs, non-steroidal anti-inflammatory drugs.
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tramadol, as a weak opioid, was still the most common 
opioid prescribed. Our data differed from the compara-
tive data20 because we included only LBP patients with 
a diagnostic imaging of the spine and not the whole 
population with acute LBP. The same issue is true for 
the international comparative data as opioid treatment 
rates reported from the USA are similar, but the popula-
tion studied included all patients with LBP and not 
specifically patients with diagnostic imaging.5
Many different factors could contribute to this differ-
ence. Conversely, providers’ clinical knowledge is asso-
ciated with the use of opioids27 and it is known that many 
diagnostic images are inappropriate. However, many dif-
ferent patient factors may have contributed to the 
increased opioid prescription rates. For example, patients 
who had undergone diagnostic imaging could perhaps 
have suffered from more intense pain than the general 
population of patients with acute LBP. In fact, a study 
from the United Kingdom showed that patients with opioid 
treatments suffered from higher pain intensities.23 
Similarly, further patient factors such as comorbidities, 
distress, or the degree of mobility impairment appeared 
to have an impact on individual treatment patterns23,28 and 
may be more prevalent in patients who had undergone 
diagnostic imaging. However, to the best of our knowl-
edge, there are no specific studies investigating the com-
plex interplay between patient and provider factors, 
treatment patterns, and diagnostic imaging in patients 
with acute LBP. Nevertheless, the high rates of diagnostic 
imaging in acute LBP9,10 and the apparent higher rates of 
opioid treatments in these patients highlight the relevance 
of international initiatives promoting the conservative use 
of diagnostic imaging in acute LBP.29,30
Strong opioids were approximately one third of all 
opioid prescriptions in our study and we observed a shift 
towards strong opioid usage after diagnostic imaging, with 
significantly more prescriptions for strong opioids like 
morphine, fentanyl, or oxycodone. However, our findings 
that strong opioids were only used in a small group of 
patients and that only a few patients had monotherapies 
Table 3 Prescribed Pain Medications per Patient (in Defined Daily Doses, DDD) Depending on Time of Prescription and Imaging 
Method
Time Period 1 2 3 4 5
X-ray
NSAID 15.00 [10.00, 33.33] 15.00 [10.00, 40.00] 15.00 [10.00, 45.00] 15.00 [9.00, 40.00]
Paracetamol 16.67 [6.67, 40.00] 18.67 [8.00, 44.00] 22.00 [9.33, 45.33] 18.67 [6.67, 38.67]
Opioids 5.00 [3.33, 18.67] 4.67 [3.33, 14.00] 6.67 [3.33, 18.00] 6.67 [3.33, 18.67]
MRI
NSAID 15.00 [10.00, 40.67] 16.67 [10.00, 45.00] 20.00 [10.00, 50.00] 15.00 [10.00, 45.00]
Paracetamol 16.00 [6.67, 38.67] 18.67 [10.67, 40.00] 20.00 [6.67, 40.00] 16.67 [6.67, 33.33]
Opioids 4.67 [3.33, 16.67] 4.67 [3.33, 14.00] 7.40 [3.33, 18.50] 6.67 [3.33, 20.00]
CT
NSAID 15.00 [10.00, 45.00] 15.00 [10.00, 45.00] 15.00 [10.00, 50.00] 15.00 [10.00, 50.00]
Paracetamol 17.33 [6.67, 46.67] 18.67 [6.67, 45.33] 21.33 [6.67, 46.67] 20.00 [8.33, 46.67]
Opioids 10.00 [3.33, 27.67] 5.13 [3.33, 16.00] 7.75 [3.33, 23.46] 8.00 [3.33, 20.00]
X – ray/MRI
NSAID 15.00 [10.00, 45.00] 20.00 [10.00, 45.00] 20.00 [10.00, 50.00] 20.00 [10.00, 50.00] 16.67 [10.00, 50.00]
Paracetamol 16.67 [6.67, 36.55] 20.00 [10.67, 40.00] 18.67 [6.67, 33.33] 26.67 [11.33, 40.00] 20.00 [10.00, 46.67]
Opioids 4.67 [3.33, 15.00] 4.67 [3.33, 14.00] 6.67 [3.33, 14.00] 8.00 [3.33, 18.67] 7.50 [3.33, 20.00]
X- ray/CT
NSAID 15.00 [10.00, 50.00] 16.67 [10.00, 50.00] 15.00 [10.00, 33.33] 16.67 [10.00, 50.00] 20.00 [10.00, 50.00]
Paracetamol 21.33 [7.33, 51.00] 26.67 [11.33, 46.67] 20.00 [6.67, 37.33] 32.67 [13.33, 66.67] 33.33 [13.33, 66.67]
Opioids 10.00 [3.33, 24.50] 5.00 [3.33, 16.67] 6.67 [3.33, 15.50] 10.00 [3.33, 26.33] 13.00 [4.67, 26.50]
Note: Numbers were presented as median and interquartile range (in square brackets). 
Abbreviations: NSAID, non-steroidal anti-inflammatory drug; MRI, magnetic resonance imaging; CT, computed tomography scan.
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with opioids could be seen as an indication for their 
prudent use. Furthermore, the median prescribed DDDs 
corresponded to only one to two weeks of treatment and 
the upper IQR seldom surpassed a treatment duration of 
longer than three weeks. In addition to patient character-
istics, provider factors and local routines may influence 
prescribing behavior.20,24,31,32 Thus, further studies are 
needed to identify patient groups at risk, and provider 
characteristics associated with increased and perhaps 
unnecessary opioid prescriptions in the Swiss healthcare 
setting.
Non-Pharmacologic Therapies
Physiotherapy was the most frequent treatment option 
although only a few international guidelines recommend 
physiotherapy for acute LBP3 and the evidence for efficacy 
is low.31 Compared to a large USA cohort, the proportion of 
physiotherapy use was threefold higher in our study.26 
Similarly, the proportion of physiotherapy use was twofold 
higher compared to a representative national survey among 
patients with LBP.33 Significantly less frequent, when com-
pared to physiotherapy, was the use of chiropractic therapy, 
the efficacy of which is also questionable.34,35 Overall, the 
use of NPT was higher in patients with a concomitant pain 
medication therapy and patients with NPT had more pre-
scriptions and higher prescribed DDDs. In addition, patients 
with NPT were older on average and had more comorbid-
ities compared to patients without NPT. Thus, it seemed that 
NPT were used as an additional treatment option rather than 
as an alternative therapy. Therefore, the association 
between physiotherapy and opioid prescriptions also 
remained unclear. In contrast to some evidence, which 
suggested a positive effect of physiotherapy on opioid 
prescriptions,36,37 we found even higher odds of receiving 
an opioid in patients with physiotherapy, as shown 
previously.38
Strengths and Limitations
To the best of our knowledge, this study was the first to 
perform an analysis of pain medication therapies in a large 
number of patients who had undergone diagnostic imaging 
for LBP in Switzerland. By calculating the prescribed 
DDDs we gained important insights into national prescrib-
ing patterns. This is relevant as the long-term use of 
opioids in non-cancer pain is a considerable concern; an 
increasing use of opioids can also be observed in Western 
Europe as well as the USA.39
Our study had some limitations. First, owing to our 
inclusion procedure, we could not definitely rule out errors 
during patient selection. As we could not collect any 
clinical data, there was a chance that patients received 
imaging studies not exclusively for LBP. However, a 
long pre-observation period of 12 months, the exclusion 
of all patients who had undergone back surgery, and the 
exclusion of patients with comorbidities associated with 
the use of pain medications, minimized the selection bias. 
At the same time, there was a risk that patients may have 
been incorrectly excluded. In fact, we excluded patients 
with an unspecific TARMED Code of the spine if they had 
at the same time a specific TARMED code for an adjacent 
anatomic region (for example simultaneous codes for CT 
of the spine and CT of the skull), as these combinations 
could indicate that the pathology was not exclusively 
related to the lumbar spine. We are aware of the possibility 
that a patient may have had a CT of the spine for LBP and 
at the same time, a CT for an adjacent anatomic region for 
another unrelated pathology.
Second, because GM is more active in the French- 
speaking part of Switzerland, patients from this area 
were overrepresented. However, the basic characteristics 
of our patients (age and gender) were similar to those 
reported in a previous study investigating LBP in the 
primary care setting in the German-speaking area of 
Switzerland.20 Third, we were unaware of any pain med-
ications purchased by patients over the counter (OTC) 
which were not reimbursed by GM. Back pain is a fre-
quent reason for OTC purchase of pain medications.40 
Thus, our calculations regarding NSAIDs and paracetamol 
could underestimate the real intake of pain medications. 
However, because opioids are not available for OTC pur-
chases, our findings regarding opioids were not affected by 
this bias. Finally, we were unable to consider other thera-
pies, such as epidural injections, which may have influ-
enced the use of oral analgesics.
Conclusion
The majority of patients who had undergone diagnostic 
imaging for LBP received non-opioid and short-term pain 
medication therapies, in accordance with international 
guidelines. Nevertheless, the rate of opioid use was high, 
particularly for strong opioids. Given the scant evidence of 
their effectiveness in acute LBP and the potential adverse 
outcomes and addiction associated with the use of opioids 
in non-cancer patients, the findings of our study 
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emphasized the importance of the prudent use of opioids 
in patients with LBP.
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